Search company, investor...
Organovo company logo


Founded Year



Reverse Merger | IPO

Total Raised


Market Cap


Stock Price


About Organovo

Organovo is focused on delivering three-dimensional biology capabilities to create tissue on demand for research and surgical applications.

Headquarters Location

440 Stevens Ave Suite 200

Solana Beach, California, 92075,

United States

Missing: Organovo's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Organovo's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Organovo

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Organovo is included in 1 Expert Collection, including Drug Discovery Tech Market Map.


Drug Discovery Tech Market Map

221 items

This CB Insights Tech Market Map highlights 220 drug discovery companies that are addressing 12 distinct technology priorities that pharmaceutical companies face.

Organovo Patents

Organovo has filed 47 patents.

The 3 most popular patent topics include:

  • Drug discovery
  • Transcription factors
  • Pharmaceutical industry
patents chart

Application Date

Grant Date


Related Topics




Digestive system, Drug discovery, Hepatotoxins, Pharmaceutical industry, Pharmacokinetics


Application Date


Grant Date



Related Topics

Digestive system, Drug discovery, Hepatotoxins, Pharmaceutical industry, Pharmacokinetics



Latest Organovo News

Know How 3D Bioprinting Market Will Boom in the Next Decade | Organovo Holdings, EnvisionTEC, 3Dynamic Systems

May 9, 2023

| Organovo Holdings, EnvisionTEC, 3Dynamic Systems News Provided By Share This Article 3D Bioprinting Market1 PORTLAND, OR, UNITED STATES, May 9, 2023 / / -- 3D Bioprinting Market - Global Outlook and Forecast 2023-2030 is latest research study released by Allied Market Research evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support (2023-2030). The market Study is segmented by key a region that is accelerating the marketization. The report provides information on market research and development, growth drivers, and the changing investment structure of the Global 3D Bioprinting Market. Some of the key players profiled in the study are Organovo Holdings, EnvisionTEC, Nano3D Biosciences, Cyfuse Biomedical, BioBots, Aspect Biosystems, 3Dynamic Systems. Click To get FREE SAMPLE PDF (Including Full TOC, Table & Figures): 3D bioprinting is a technology that allows the creation of three-dimensional living tissue constructs using a specialized printer. This technology combines biology, engineering, and materials science to create functional tissues that can be used for a variety of purposes, including drug discovery, tissue engineering, and transplantation. 3D bioprinting has the potential to revolutionize medicine by providing a means of creating complex tissue structures that can be used for transplantation and drug testing. It also has the potential to overcome the shortage of donor organs by allowing the creation of personalized tissues and organs that are compatible with a patient's immune system. However, there are still many technical and regulatory challenges that must be overcome before 3D bioprinting can be widely used in clinical practice. 3D Bioprinting Market: Demand Analysis & Opportunity Outlook 2030 3D Bioprinting research study defines market size of various segments & countries by historical years and forecast the values for next 7 years. The report is assembled to comprise qualitative and quantitative elements of 3D Bioprinting industry including: market share, market size (value and volume 2017-2021, and forecast to 2030) that admires each country concerned in the competitive marketplace. Further, the study also caters and provides in-depth statistics about the crucial elements of 3D Bioprinting which includes drivers & restraining factors that helps estimate future growth outlook of the market. Marketing Communication and Sales Channel Understanding “marketing effectiveness” on a continual basis, help determine the potential of advertising and marketing communications and allow to use of best practices to utilize untapped audience. In order to make marketers make effective strategies and identify why the target market is not giving attention, we ensure the Study is Segmented with appropriate marketing & sales channels to identify potential market size by value & Volume* (if Applicable). Have Any Query? Ask Our Expert @: The segments and sub-section of 3D Bioprinting market is shown below: By Technology: Syringe, Pneumatic Extrusion, Inkjet, Laser, Others By Material: Cells, Hydrogels, Extracellular Matrices, Biomaterials By Application: Tissue Organ Regeneration, 3D Cell Culture, Pharmaceutical Some of the key players involved in the Market are: Organovo Holdings, EnvisionTEC, Nano3D Biosciences, Cyfuse Biomedical, BioBots, Aspect Biosystems, 3Dynamic Systems. Important years considered in the 3D Bioprinting study: Historical year – 2017-2021; Base year – 2021; Forecast period** – 2022 to 2030 [** unless otherwise stated] If opting for the Global version of 3D Bioprinting Market; then below country analysis would be included: – North America (USA, Canada and Mexico) – Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland and Rest of Europe) – Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia and Rest of APAC) – South America (Brazil, Argentina, Chile, Colombia, Rest of countries etc.) – Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA) Key Questions Answered with this Study: 1) What makes 3D Bioprinting Market feasible for long term investment? 2) How influencing factors driving the demand of 3D Bioprinting in next few years? 3) Territory that may see steep rise in CAGR & Y-O-Y growth? 4) What geographic region would have better demand for product/services? 5) What opportunity emerging territory would offer to established and new entrants in 3D Bioprinting market? 6) What strategies of big players help them acquire share in mature market? 7) Know value chain areas where players can create value? 8) What is the impact analysis of various factors in the Global 3D Bioprinting market growth? 9) Risk side analysis connected with service providers? Introduction about 3D Bioprinting Market 3D Bioprinting Market Size (Sales) Market Share by Type (Product Category) 3D Bioprinting Market by Application/End Users 3D Bioprinting Sales (Volume) and Market Share Comparison by Applications Global 3D Bioprinting Sales and Growth Rate (2020-2030) 3D Bioprinting Competition by Players/Suppliers, Region, Type, and Application 3D Bioprinting (Volume, Value, and Sales Price) table defined for each geographic region defined. 3D Bioprinting Players/Suppliers Profiles and Sales Data Key Raw Materials Analysis & Price Trends Supply Chain, Sourcing Strategy and Downstream Buyers, Industrial Chain Analysis ……..and view more in complete table of Contents Procure Complete Report (220+ Pages PDF with Insights, Charts, Tables, and Figures) @ Thanks for reading this article; you can also get an individual chapter-wise sections or region-wise report versions like North America, LATAM, Europe, or Southeast Asia. Read More Articles: Respiratory Care Devices Market Update 2023–2030: Neurostimulation Devices Market Update 2023–2030: David Correa

Organovo Frequently Asked Questions (FAQ)

  • When was Organovo founded?

    Organovo was founded in 2007.

  • Where is Organovo's headquarters?

    Organovo's headquarters is located at 440 Stevens Ave, Solana Beach.

  • What is Organovo's latest funding round?

    Organovo's latest funding round is Reverse Merger.

  • How much did Organovo raise?

    Organovo raised a total of $3.5M.

  • Who are the investors of Organovo?

    Investors of Organovo include Real Estate Restoration & Exchange Commission and Richmond Global.

  • Who are Organovo's competitors?

    Competitors of Organovo include Mercator MedSystems, TransMedics, ClearCount Medical Solutions, ApaTech, Visiogen and 12 more.

Compare Organovo to Competitors

Surikat Group

Surikat develops x-ray protection shields for children

TransMedics Logo

TransMedics offers portable ex-vivo perfusion and assessment of donor organs for transplantation. The company was founded to address the need for organ transplantation. It focuses on transforming organ utilization, improving patient outcomes, and reducing transplant costs throughout the health care system. The platform develops technology for preserving organs used in the treatment of end-stage heart, lung, and liver failure. The company was founded in 1998 and is based in Andover, Massachusetts.

NeoChord Logo

NeoChord is a medical technology company engaged in the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, is a beating heart procedure, echo-guided treatment for patients with mitral valve regurgitation and is proven to resolve and restore normal mitral valve function. The company was founded in 2007 and is based in Minneapolis, Minnesota.


Prosurgics develops the FreeHand Surgeon, a robotic camera holder

C Change Biosciences

C Change Surgical Llc is a medical device company. It had developed the Intratemp Solution Warmer.Introducing IntraTemp, it will take the uncertainty out of surgical fluids. IntraTemp defines the new standard of care in portable controlled-temperature for irrigation and lavage fluids. Instead of warming fluids away from where you are using them, IntraTemp is completely mobile, allowing for a more efficient way to guarantee the correct temperature to your patients. It will reduce risks for your patients and stress for your staff. It puts temperature control where you need it, when you need it. IntraTemp provides temperature data for chartable proof of quality care.

INRange Systems

INRange Systems offers the EMMA system which manages outpatient medication delivery by selecting and delivering individual doses of medication for the patient in accordance with the physician's and pharmacist's instructions. The EMMA system aims to address the problem of noncompliance and drug errors has become an epidemic.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.